Metropolitan Life Insurance CO Voyager Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $2.27 Billion
  • Q1 2024

A detailed history of Metropolitan Life Insurance CO transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Metropolitan Life Insurance CO holds 1,743 shares of VYGR stock, worth $13,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,743
Previous 1,743 -0.0%
Holding current value
$13,473
Previous $14,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$6.94 - $13.99 $12,096 - $24,384
1,743 New
1,743 $19,000
Q4 2020

Feb 16, 2021
SELL
$7.15 - $12.28 $64,693 - $111,109
-9,048 Closed
0 $0
Q3 2020

Jun 26, 2023
BUY
$10.01 - $13.75 $90,570 - $124,410
9,048 New
9,048 $96,000
Q2 2020

Jun 26, 2023
BUY
$8.05 - $14.21 $72,836 - $128,572
9,048 New
9,048 $114,000
Q1 2020

Jul 12, 2023
BUY
$6.8 - $14.66 $61,526 - $132,643
9,048 New
9,048 $82,000
Q4 2019

Jul 12, 2023
BUY
$12.82 - $16.85 $115,995 - $152,458
9,048 New
9,048 $126,000
Q3 2019

Jul 12, 2023
BUY
$16.31 - $28.29 $147,572 - $255,967
9,048 New
9,048 $155,000
Q2 2019

Jul 12, 2023
BUY
$19.18 - $27.88 $173,540 - $252,258
9,048 New
9,048 $246,000
Q1 2019

Jul 13, 2023
BUY
$8.0 - $19.66 $72,384 - $177,883
9,048 New
9,048 $173,000
Q1 2019

Mar 30, 2023
BUY
$8.0 - $19.66 $72,384 - $177,883
9,048 New
9,048 $173,000
Q1 2019

May 16, 2019
SELL
$8.0 - $19.66 $56,680 - $139,291
-7,085 Reduced 43.92%
9,048 $173,000
Q1 2019

May 15, 2019
BUY
$8.0 - $19.66 $56,680 - $139,291
7,085 Added 78.3%
16,133 $1.09 Million
Q4 2018

Jul 13, 2023
BUY
$8.59 - $18.05 $77,722 - $163,316
9,048 New
9,048 $85,000
Q4 2018

Feb 14, 2019
BUY
$8.59 - $18.05 $63,574 - $133,588
7,401 Added 449.36%
9,048 $85,000
Q3 2018

Jul 13, 2023
BUY
$17.11 - $21.74 $154,811 - $196,703
9,048 New
9,048 $171 Million
Q3 2018

Nov 14, 2018
SELL
$17.11 - $21.74 $126,631 - $160,897
-7,401 Reduced 81.8%
1,647 $31,000
Q2 2018

Aug 15, 2018
BUY
$16.76 - $23.92 $52,911 - $75,515
3,157 Added 53.59%
9,048 $0
Q4 2017

Feb 15, 2018
SELL
$12.26 - $25.88 $63,653 - $134,368
-5,192 Reduced 46.85%
5,891 $98,000
Q3 2017

Nov 14, 2017
BUY
$8.37 - $20.59 $92,764 - $228,198
11,083
11,083 $228,000

Others Institutions Holding VYGR

# of Institutions
134
Shares Held
34.2M
Call Options Held
35.3K
Put Options Held
63K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $299M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email